The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization

NCT05970185 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Granulocyte Colony-Stimulating Factor

Interventions

DRUG: PEG-rhG-CSF
DRUG: G-CSF

Sponsor

Zhongnan Hospital